Skip to content
Open access · CC-BY via OpenAlex

Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia

Alexandra M. Cheney, Stephanann M. Costello, Nicholas V. Pinkham, Annie Waldum, Susan C. Broadaway, Maria L. Cotrina-Vidal, Marc A. Mergy, Brian Tripet, Douglas J. Kominsky, Heather M. Grifka‐Walk, Horacio Kaufmann, Lucy Norcliffe‐Kaufmann, Jesse T. Peach, Brian B. Bothner, Frances B. Lefcort

Nature Communications · 2023 · ▲ 17 citations

Abstract

Familial dysautonomia (FD) is a rare genetic neurologic disorder caused by impaired neuronal development and progressive degeneration of both the peripheral and central nervous systems. FD is monogenic, with >99.4% of patients sharing an identical point mutation in the elongator acetyltransferase complex subunit 1 (ELP1) gene, providing a relatively simple genetic background in which to identify modifiable factors that influence pathology. Gastrointestinal symptoms and metabolic deficits are common among FD patients, which supports the hypothesis that the gut microbiome and metabolome are altered and dysfunctional compared to healthy individuals. Here we show significant differences in gut microbiome composition (16 S rRNA gene sequencing of stool samples) and NMR-based stool and serum metabolomes between a cohort of FD patients (~14% of patients worldwide) and their cohabitating, healthy relatives. We show that key observations in human subjects are recapitulated in a neuron-specific Elp1-deficient mouse model, and that cohousing mutant and littermate control mice ameliorates gut microbiome dysbiosis, improves deficits in gut transit, and reduces disease severity. Our results provide evidence that neurologic deficits in FD alter the structure and function of the gut microbiome, which shifts overall host metabolism to perpetuate further neurodegeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1038/s41467-023-35787-8
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Cheney, A.M., Costello, S.M., Pinkham, N.V., Waldum, A., Broadaway, S.C., Cotrina-Vidal, M.L., Mergy, M.A., Tripet, B., Kominsky, D.J., Grifka‐Walk, H.M., Kaufmann, H., Norcliffe‐Kaufmann, L., Peach, J.T., Bothner, B.B., Lefcort, F.B., Copié, V., &amp; Walk, S.T. (2023). Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-023-35787-8
Vancouver
Cheney AM, Costello SM, Pinkham NV, Waldum A, Broadaway SC, Cotrina-Vidal ML, et al. Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia. Nature Communications. 2023. doi:10.1038/s41467-023-35787-8.
BibTeX
@article{alexandra2023Gutmic, title = {Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia}, author = {Alexandra M. Cheney and Stephanann M. Costello and Nicholas V. Pinkham and Annie Waldum and Susan C. Broadaway and Maria L. Cotrina-Vidal and Marc A. Mergy and Brian Tripet and Douglas J. Kominsky and Heather M. Grifka‐Walk and Horacio Kaufmann and Lucy Norcliffe‐Kaufmann and Jesse T. Peach and Brian B. Bothner and Frances B. Lefcort and Valérie Copié and Seth T. Walk}, journal = {Nature Communications}, year = {2023}, doi = {10.1038/s41467-023-35787-8}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings